Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis
| Autor: | Naci, Huseyin *, Zhang, Yichen, Woloshin, Steven, Guan, Xiaodong, Xu, Ziyue, Wagner, Anita K |
|---|---|
| Zdroj: | In The Lancet Oncology June 2024 25(6):760-769 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|